The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 425.00
Bid: 426.30
Ask: 426.50
Change: 4.40 (1.05%)
Spread: 0.20 (0.047%)
Open: 422.00
High: 428.60
Low: 422.00
Prev. Close: 420.60
RTO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Joint venture with Haniel

16 Dec 2016 07:00

RNS Number : 0212S
Rentokil Initial PLC
16 December 2016
 

JOINT VENTURE WITH HANIEL

Delivering Shareholder Value

 

Rentokil Initial plc (FTSE: RTO, "the Company") and Haniel & Cie. Holding Company ("Haniel") have today entered into an agreement to form a joint venture ("the JV"), creating a leading provider of Workwear and Hygiene services in Europe with combined revenues of c. €1.1bn and APBITA of c. €130m (12 months to 30 June 2016).

 

The joint venture brings together Rentokil Initial's Workwear and Hygiene businesses ("the Rentokil Initial businesses") in 10 countries principally in the Benelux and Central & Eastern Europe regions, together with Haniel's businesses in 17 countries which operate under the CWS-boco brand.

Key points:

The joint venture will be formed through the transfer of the Rentokil Initial businesses into CWS-boco, a company owned by Haniel. The valuation of Rentokil Initial's businesses transferring into the JV reflects good value at a multiple of 15.2 times APBITA (12 months to 30 June 2016). In consideration for the transfer, Rentokil Initial will receive around €520m in cash and a c. 18% stake in the joint venture, subject to working capital and other adjustments. In relation to its investment in the JV, the Company will receive an annual fixed dividend of €19m for five years.The Rentokil Initial and CWS-boco businesses have complementary operations, products and capabilities providing the potential for future growth, as well as synergies and efficiencies.The transaction is a strong fit with the Company's capital allocation model:

o The cash received provides increased capacity for investment in its core Pest Control and Hygiene categories in its Growth and Emerging quadrants - with guidance for expenditure on bolt-on acquisitions in 2017 now increased to £100m.

o Rentokil Initial also protects value in its Protect & Enhance markets through an investment in a leading European Workwear & Hygiene business.

Proceeds will be used to reduce net debt and provide increased flexibility for value-enhancing acquisitions in Pest Control and Hygiene. The Company's pro forma Net Debt:EBITDA ratio (as at 30 June 2016) would be reduced from 2.5x to c 2.0x and there would also be a pro forma reduction in annual interest costs of c. £7m.Rentokil Initial anticipates maintaining its stake in the joint venture for a minimum period of three years, and for an anticipated period of five years, after which the Company has various exit options under the agreement to optimise further value for shareholders.The transaction also provides the potential for a strategic alliance between Rentokil Initial's Pest Control business and the joint venture, as well as for the development of Hygiene technology to support the joint venture and Rentokil Initial's retained Hygiene operations. In continental Europe the Company will retain its Pest Control, Plants, Specialist Hygiene, Premium Scenting, Medical, Dental and other operations in the countries in which the Rentokil Initial businesses are transferring to CWS-boco, as well as its Workwear and Hygiene businesses in France. Completion of the transaction is subject to clearance from the competition authorities and will take place after appropriate consultation with employees. The target for completion is mid-2017.

 

 

 

Andy Ransom, Chief Executive of Rentokil Initial, commented:

 

"We are delighted to announce this joint venture with Haniel, a high-quality organisation with people who share our drive for value creation, respect for colleagues and passion for customer service. This is the right deal at the right time and the next step in the implementation of our RIGHT WAY plan.

 

"Overall, I believe there is a compelling logic in bringing our respective Workwear and Hygiene businesses together in these European markets, freeing up capital to invest in our higher-growth markets and delivering value for our shareholders.

 

"Our expectations for the full year ended 31 December 2016 remain unchanged."

 

Stephan Gemkow, Chief Executive of Haniel, commented: 

 

"Our acquisition and the establishment of the joint venture will further improve the future viability of our sustainable portfolio. CWS-boco and Initial will have an excellent opportunity to continue their current successful development in the attractive market for workwear, cleanroom and hygiene services."

Focus on Growth and Emerging markets:

Rentokil Initial has been pursuing a strategy of growth in its Pest Control and Hygiene businesses with particular focus on its Growth and Emerging markets. Post completion the pro forma percentage of the Company's revenues from these higher-growth markets will rise to above 70%. Pest Control will account for around 60% of revenues and over 60% of profits, and Hygiene will account for around 20% of revenues and profits respectively.

Funds will be used to reduce net debt and provide increased flexibility for value-enhancing acquisitions in Pest Control and Hygiene, with guidance for expenditure on bolt-on acquisitions in 2017 now increased to £100m.

The Company's Workwear business in the transferring countries is significantly integrated with Rentokil Initial's Hygiene operations in those same countries. Elsewhere, Rentokil Initial's Hygiene businesses typically operate alongside its Pest Control businesses. Rentokil Initial remains fully committed to its global Hygiene business (which operates in over 30 countries).

Other key aspects of the transaction:

The Company expects a run-rate reduction in its central and regional overheads as a result of the transaction of c. £5m by the end of 2017.One-off costs for Rentokil Initial (including transaction costs) are estimated to be in the region of £20m.Rentokil Initial's 10 businesses being deployed into the joint venture delivered revenues of €328m and APBITA of €53m (12 months to 30 June 2016 at 2015 CER).The €520m cash to be received by Rentokil Initial will be funded through debt raised by the joint venture. This debt will initially be provided to the joint venture by Haniel at market based interest rates.The net impact of the sale is expected to be slightly dilutive on Adjusted EPS in the first year after completion of c. 0.4p. Taking into account the fixed dividend, the pro forma impact on free cash flow (excluding one-offs) in the 12 months after completion is an estimated reduction of c. £10m.On a pro forma basis the transaction is expected to improve Rentokil Initial's underlying organic revenue growth, profit growth and adjusted PBTA margins. The estimated profit on transfer of the Rentokil Initial businesses into the joint venture is c. €540m based on net assets of approximately €265m. As part of the transaction the Company has the option to purchase Haniel's Hygiene businesses in Italy and Ireland (which generated revenues of around €50m for the year ended December 2015).

This announcement contains inside information and the person responsible for making this announcement is Daragh Fagan, Group General Counsel and Company Secretary.

-ends-

 

Enquiries:

 

Investors / Analysts:

Katharine Rycroft

Rentokil Initial plc

07811 270734

 

 

 

 

Media:

Malcolm Padley

Rentokil Initial plc

07788 978 199

 

John Sunnucks

Bell Pottinger

0203 772 2549

 

 

Conference call for investors and analysts

 

A conference call for investors and analysts will be held at 9.15am on Friday, 16 December 2016. A copy of the presentation that will be used during the call can be accessed on the home page of the Company's website, www.rentokil-initial.com.

 

Participant access telephone numbers:

 

UK:

+44 (0)330 336 9105

France:

+33 (0)1 76 77 22 74

Hong Kong:

+852 6963 0854

USA:

+1 719-325-2202

 

 

 

 

The conference ID for this call is 8882788

 

 

Notes to editors:

The Haniel Workwear and Hygiene businesses in the joint venture include:

• Belgium, Netherlands, Luxembourg, Germany, Austria, Switzerland, Czech Republic, Slovakia, Poland, Sweden, Bulgaria, Croatia, Hungary, Romania, Slovenia, Italy and Ireland.

 

The Rentokil Initial Workwear and Hygiene businesses in the joint venture include:

• Belgium, Netherlands, Luxembourg, Germany, Austria, Switzerland, Czech Republic, Slovakia, Poland and Sweden.

 The joint venture does not include:

• Pest Control, Plants, Specialist Hygiene, Premium Scenting, Medical, Dental and other operations in the above countries.

• All businesses in France.

• In Italy and Ireland, the Company retains all businesses and has agreed an option to acquire Haniel's Hygiene businesses in these countries.

• All businesses outside of continental Europe.

 

Rentokil Initial plc

Rentokil Initial is one of the largest business services companies in the world, operating in over 60 countries. The Company offers route-based services including Pest Control, Hygiene and Workwear through teams of local experts. For more information, visit www.rentokil-initial.com.

Haniel & Cie. GmbH

Franz Haniel & Cie. GmbH is a German family equity company which has been headquartered in Duisburg-Ruhrort since it was founded in 1756. It is from there that the Holding Company, which is wholly owned by the family, manages a diversified portfolio in line with a long-term investment strategy as a value developer. Haniel's portfolio currently includes four business divisions which are independently responsible for their own operating business and which hold a leading market position in their respective sectors: BekaertDeslee, CWS-boco and ELG (wholly owned), TAKKT (majority owned). In addition there is the METRO GROUP financial investment. For more information, visit www.haniel.com.

CWS-boco

CWS-boco International GmbH is one of the leading international providers of professional textile services and washroom hygiene solutions. This includes the well-known CWS cotton towel, soap and fragrance dispensers and dust control mats, as well as industrially washable workwear and business wear, customer-specific corporate fashion collections, protective clothing from boco.

All services are offered in a flexible rental service. The CWS-boco Group achieved a turnover of €779 million in 2015. The company has 17 subsidiaries in Europe and China and employs around 7,500 employees around the globe. CWS-boco is wholly owned by Franz Haniel & Cie. GmbH. Further information can be found at: www.cws-boco.com.

 

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
JVELELLFQLFFFBK
Date   Source Headline
8th May 20242:00 pmRNSResult of AGM
29th Apr 20243:00 pmRNSHolding(s) in Company
23rd Apr 20249:30 amRNSHolding(s) in Company
18th Apr 20247:00 amRNSQ1 Trading Update
2nd Apr 20241:28 pmRNSBlock listing Interim Review
2nd Apr 202412:17 pmRNSTotal Voting Rights
27th Mar 202410:23 amRNSAnnual Financial Report
19th Mar 20242:05 pmRNSAdditional Listing
14th Mar 202410:19 amRNSDirector/PDMR Shareholding
7th Mar 20247:00 amRNSFinal Results
1st Dec 20237:00 amRNSNorth American Management Changes
10th Nov 20232:28 pmRNSDirector/PDMR Shareholding
3rd Nov 20234:26 pmRNSHolding(s) in Company
3rd Nov 20234:22 pmRNSDirector/PDMR Shareholding
1st Nov 202312:50 pmRNSHolding(s) in Company
31st Oct 202311:45 amRNSHolding(s) in Company
30th Oct 20233:03 pmRNSDirector/PDMR Shareholding
30th Oct 202311:55 amRNSCredit rating update
19th Oct 20237:00 amRNSQ3 Trading Update
2nd Oct 202311:35 amRNSBlock listing Interim Review
27th Sep 20232:35 pmRNSDirector/PDMR Shareholding
1st Aug 202312:42 pmRNSDirector/PDMR Shareholding
27th Jul 20237:00 amRNS2023 Interim Results
29th Jun 20239:00 amRNSNotice of Management Presentation
23rd Jun 20235:58 pmRNSDirector/PDMR Shareholding
19th May 20233:03 pmRNSDirector/PDMR Shareholding
12th May 20239:09 amRNSDirector/PDMR Shareholding
11th May 20239:17 amRNSResult of AGM
28th Apr 202310:55 amRNSHolding(s) in Company
21st Apr 20232:41 pmRNSDirector/PDMR Shareholding
20th Apr 20237:00 amRNSQ1 Trading Update
4th Apr 20239:37 amRNSAnnual Financial Report
3rd Apr 202310:08 amRNSBlock listing Interim Review
23rd Mar 20239:42 amRNSDirector/PDMR Shareholding
20th Mar 20234:47 pmRNSDirector/PDMR Shareholding
16th Mar 20237:05 amRNSDirectorate Change
16th Mar 20237:00 amRNSFinal Results
9th Mar 20239:23 amRNSDirector Declaration
27th Feb 20238:55 amRNSNotice of Management Presentation
9th Nov 20224:33 pmRNSDirector Declaration
1st Nov 20222:25 pmRNSCorrection: Q3 Trading Update
1st Nov 20227:00 amRNSQ3 Trading Update
31st Oct 20224:03 pmRNSTotal Voting Rights
24th Oct 20225:15 pmRNSHolding(s) in Company
21st Oct 20224:42 pmRNSHolding(s) in Company
20th Oct 202212:35 pmRNSHolding(s) in Company
19th Oct 202211:43 amRNSHolding(s) in Company
18th Oct 20225:22 pmRNSHolding(s) in Company
17th Oct 20226:07 pmRNSHolding(s) in Company
17th Oct 202211:51 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.